|
Volumn 9, Issue 3, 2009, Pages 54-60
|
Should clinicians routinely determine rhinitis subtype on initial diagnosis and evaluation? A debate among experts
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALLERGEN;
ANTIHISTAMINIC AGENT;
ANTIHYPERTENSIVE AGENT;
CARDIOVASCULAR AGENT;
CORTICOSTEROID;
DECONGESTIVE AGENT;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
NON PRESCRIPTION DRUG;
NONSTEROID ANTIINFLAMMATORY AGENT;
ORAL CONTRACEPTIVE AGENT;
ALLERGIC RHINITIS;
ANAMNESIS;
ARTICLE;
DIAGNOSTIC TEST;
DIFFERENTIAL DIAGNOSIS;
DISEASE ASSOCIATION;
DISEASE CLASSIFICATION;
DISEASE EXACERBATION;
DISEASE PREDISPOSITION;
DRUG RESPONSE;
EVIDENCE BASED MEDICINE;
FAMILY HISTORY;
HUMAN;
IMMUNOPATHOLOGY;
IMMUNOTHERAPY;
INFLAMMATORY DISEASE;
MEDICAL DECISION MAKING;
MEDICAL EXPERT;
NOSE CONGESTION;
PATIENT ASSESSMENT;
PATIENT CARE;
PHYSICAL EXAMINATION;
PRACTICE GUIDELINE;
PREVALENCE;
PRURITUS;
RADIOALLERGOSORBENT TEST;
RHINITIS;
RHINORRHEA;
SKIN TEST;
SNEEZING;
SYMPTOM;
VASOMOTOR RHINITIS;
GLUCOCORTICOIDS;
HISTAMINE ANTAGONISTS;
HUMANS;
PRIMARY HEALTH CARE;
RADIOALLERGOSORBENT TEST;
RHINITIS;
SKIN TESTS;
|
EID: 70349196468
PISSN: 10983597
EISSN: None
Source Type: Journal
DOI: 10.1016/S1098-3597(09)80014-8 Document Type: Article |
Times cited : (10)
|
References (7)
|